MedTrace Logo

To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis

NCT00372294 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2008-07-30

No results posted yet for this study

Summary

Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin \& Dexamethasone.

Conditions

  • Chorioretinitis

Interventions

DRUG

pyrimethamine-sulfadiazine + prednisolone

Administration of pyrimethamine-sulfadiazine + prednisolone

DRUG

Clindamycin+Dexamethasone

Intravitreal injection of Clindamycin+Dexamethasone

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Masoud Soheilian, MD · Ophthalmic Research Center of Shaheed Beheshti Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-08-31
Completion
2008-11-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00372294 on ClinicalTrials.gov